AI assistant
Bartronics India Ltd. — Capital/Financing Update 2025
Dec 10, 2025
64057_rns_2025-12-10_d1bf4b31-686c-454c-a000-c58306efad90.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
10[th] December, 2025
| To, BSE Limited, Listing Department, P.J. Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 532694 |
To, National Stock exchange of India Limited, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai – 400 051 Symbol: ASMS |
|---|---|
Dear Sir/Madam,
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure - - Requirements) Regulations, 2015 Incorporation of Wholly owned Subsidiary
With reference to our earlier intimation dated 23rd September, 2025and pursuant to Regulations 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby wish to inform that the Ministry of Corporate Affairs has approved incorporation of wholly owned subsidiary of the Bartronics India Limited (“the Company”) in the name of “ BIL Healthtech Private Limited ” on December 09, 2025. The Ministry of Corporate Affairs, has issued a Certificate of Incorporation for the same.
In accordance with the requirements Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 Dated July 13, 2023 we hereby provide the requisite disclosures in the attached Annexure A.
You are requested to kindly take the above information on record.
Thanking You,
Yours Faithfully,
For Bartronics India limited
N VIDHYA Digitally signed by N VIDHYA SAGAR SAGAR REDDY Date: 2025.12.10 REDDY 17:17:56 +05'30'
N Vidhya Sagar Reddy Managing Director DIN: 09474749
Annexure A
Details required under Regulation 30 Read with Schedule III of the Securities and Exchange Board of India (“SEBI") (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR”) and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 Dated July 13, 2023.
| 2023. | ||
|---|---|---|
| Sl.no. | Particulars | Details |
| **a) ** | Name of the target entity, details in brief such as size, turnover etc. |
Name: BIL Healthtech Private Limited CIN: U62099TS2025PTC207421 Authorised Share Capital:Rs.10,00,000/- (Rupees Ten Lakhs only) divided into 1,00,000 equity shares of ₹10/-each. Paid-up Share Capital:Rs. 1,00,000/- (Rupees One Lakh only) divided into 10,000 equity shares of ₹10/-each Turnover:Not Applicable, since it is a newlyincorporated company.. |
| **b) ** | Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length”; |
BIL Healthtech Private Limited is the WOS of Bartronics India Limited (“BIL”). Accordingly, BIL Healthtech Private Limited is a related party. BIL hold 100% share capital in BIL Healthtech Private Limited. |
| **c) ** | Industry to which the entity being acquired belongs |
Health-tech services and related activities. Other Information technology and services |
| **d) ** | Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity); |
The incorporation of WOS aligns with the Company's strategic objective to diversify and expand the current business operations. |
| **e) ** | Brief details of any governmental or regulatory approvals required for the acquisition/incorporation; |
Not Applicable |
| **f) ** | Indicative time period for completion of the acquisition/incorporation |
Not Applicable |
| **g) ** | Nature of Consideration - whether cash | 100% subscription to the Share Capital will | |||
| consideration or share swap or any other | be in Cash. | ||||
| form and details of the same; | |||||
| **h) ** | Cost of acquisition and/or the price at | The initial share capital subscribed at the | |||
| which the shares are acquired; | time of Incorporation to be issued at face | ||||
| value. | |||||
| **i) ** | Percentage of shareholding | / control | 100% | ||
| acquired and / or number | of shares | ||||
| acquired | |||||
| **j) ** | Brief background about |
the entity |
BIL Healthtech Private Limited is Wholly | ||
| acquired in terms of products/line of | Owned Subsidiary of BIL incorporated in | ||||
| business acquired, date of incorporation, | Hyderabad, Telangana, India. | ||||
| history of last 3 years turnover, country | |||||
| in which the acquired entity has presence | The main objective of the wholly owned | ||||
| and any other significant information (in | subsidiary (WOS) Company is to provide | ||||
| brief); | and operate HealthTech solutions; supply | ||||
| and support medical devices; collect and | |||||
| analyse health data with related consulting | |||||
| services; and deal in biotechnology |
|||||
| products, pharmaceuticals, research tools, | |||||
| health foods, chemicals, life-science |
|||||
| equipment and other emerging technologies. | |||||
| Turnover: Not Applicable, since it is a | |||||
| newlyincorporated company. | |||||